Structured Administration and Supply Arrangement (SASA)

Structured Administration and Supply Arrangement (SASA)

TITLE: / Supply by Registered Nurses at Remote Area Nursing Posts

1. Authority:

Issued by the Chief Executive Officer of Health under Part 6 of the Medicines and Poisons Regulations 2016.

2. Scope:

This authorises Registered Nurses at approved Remote Area Nursing Posts to supply an approved medicine for the acute treatment of an approved medical condition.

3. Criteria:

This SASA authorises the actions specified in the table below.

Practitioner: / Registered Nurse /
Practice setting: / At an approved Remote Area Nursing Post listed in Appendix 1
Approved activity: / Administration or supply
Approved medicines: / Approved medicines listed in Appendix 2
Medical conditions: / Acute treatment of a person with an approved medical condition as listed in Appendix 2

4. Conditions:

The administration or supply of approved medicines under this SASA is subject to the conditions that:

The Registered Nurse is reasonably satisfied that:
The person meets any age restriction specified in Appendix 2;
The person is suffering from an approved condition listed in Appendix 2;
Acute treatment of the condition is required; and
There is no other person authorised under the Medicines and Poisons Regulations 2016 at the Post who could attend to the patient in person and prescribe or supply the medicine;

b. The quantity administered or supplied on each occasion is:

i. The smallest commercially available original treatment pack, or

ii. One full course of acute treatment appropriate to the condition;

iii. That required according to the manufacturers recommended dose for that approved medical condition and the treatment duration specified in Appendix 2;

c. Supply is not repeated for the same instance of the condition;

d. The medicines are procured by an authorised person or an appropriate Medicines and Poisons Permit holder;

e. Supply, packaging and labelling of the approved medicines is in accordance with Part 9 of the Medicines and Poisons Regulations 2016; and

f. Record keeping of supply is in accordance with Part 12 of the Medicines and Poisons Regulations 2016.

5. References:

N/A

6. Issued by:

Name: / Dr DJ Russell-Weisz
Position: / Director General
Date: / 30 January 2017
Enquiries to: / Medicines and Poisons Regulation Branch / Number: / 003/1-2017
/ Date: / 30/01/2017

APPENDIX 1

Approved Remote Area Nursing Posts

This SASA applies to the following approved Remote Area Nursing Posts:

1. / Abrolhos Island / 32. / Mulan
2. / Balgo (Wirrimanu) / 33. / Ngaanyatjarra Communities
3. / Beagle Bay / · Blackstone (Papulankutja)
4. / Bidyadanga / · Cosmo Newberry
5. / Billiluna / · Jameson (Mantamaru)
6. / Bremer Bay / · Kiwirrkurra
7. / Burringurrah Community / · Patjarr
8. / Coral Bay / · Tjirrkarli
9. / Cue / · Tjukurla
10. / Dodnun / · Warakurna
11. / Doon Doon Community (Woolah) / · Wanarn
12 / Fitzroy Crossing Hospital / · Warburton
13. / Fitzroy Valley / · Wingellina (Irrunytju)
14. / Gibb River (Ngallagunda) / 34. / Noonkanbah (Yungngora)
15. / Glen Hill Community (Mandangala) / 35. / Northcliffe
16. / Halls Creek Hospital / 36. / Nullagine
17. / Imintji / 37. / One Arm Point (Bardi)
18. / Jarmlmadangah Community / 38. / Pandanus Park (Tjarramba)
19. / Jerramungup / 39. / Parnngurr (Cotton Creek)
20. / Jigalong / 40. / Punmu
21. / Kalumburu / 41. / Ringer Soak (Kundat Djaru)
22. / Kunawarritji (Well 33) / 42. / Sandstone
23. / Lake Varley / 43. / Tjuntjunjarra (Paupiyala Tjarutja)
24. / Leinster / 44. / Warralong
25. / Lombadina / 45. / Wangkatjunka
26. / Looma / 46. / Warmun
27. / Marble Bar / 47. / Wickepin
28. / Menzies / 48. / Williams
29. / Mount Barnett (Kupungarri) / 49. / Wyndham Hospital
30 / Mount Magnet / 50. / Yalgoo
31. / Mukinbudin / 51. / Yandeyarra

APPENDIX 2

Approved Medicines and Medical Conditions

This SASA applies to the following approved medicines when administered or supplied for treatment of the associated acute medical condition:

/ Approved Medicine / Approved Patient and Condition /
1. / Albendazole (oral) / a person with –
· parasitic worm infection or evidence of parasitic infection (eosinophilia) /
2. / Amoxycillin (oral) / a person with –
· bronchitis
· otitis media /
3. / Amoxycillin / Clavulanic acid (oral) / a person with –
· urinary tract infection
a child with –
· urinary tract infection /
4. / Azithromycin + Amoxycillin + Probenecid (when packaged in a combined “Zap Pack”) / a person with –
· urethritis / cervicitis or sexual contact of such a person (single dose) /
5. / Benzathine penicillin (injection) / a person with –
· syphilis (up to 3 doses)
· impetigo (clinical risk reduction for acute rheumatic heart disease and glomerulonephritis) /
6. / Cefaclor (oral) / a child with –
· acute middle ear infection
a person with –
· upper and lower respiratory tract infection /
7. / Ceftriaxone (injection) / a person with –
· severe life threatening infection e.g. pneumonia, meningitis (single dose) /
8. / Cephalexin (oral) / a person with –
· urinary tract infection
· infected skin /
9. / Chloramphenicol (eye ointment or drops) / a person with –
· bacterial conjunctivitis
· corneal scratches / ulcers /
10. / Ciprofloxacin (ear drops) / a person with –
· chronic suppuratives otitis media /
/ Approved Medicine / Approved Patient and Condition /
11. / Co-trimoxazole (oral) / a person with –
· skin infection, where the person is from a remote indigenous community in central or northern Australia
a child with –
· urinary tract infection
· skin infection, when the child is from a remote indigenous community in central or northern Australia /
12. / Doxycycline (oral) / a person greater than 8 years of age with –
· respiratory tract infection /
13. / Flucloxacillin (oral) / a person with –
· skin infection
· mastitis /
14. / Framycetin / Dexamethasone / Gramicidin (ear drops) / a person with –
· otitis externa
· chronic suppurative otitis media /
15. / Glyceryl trinitrate or
Isosorbide dinitrate (oral) / a person with -
· angina /
16. / Hyoscine butylbromide (oral) / a person with –
· biliary colic /
17. / Iron polymaltose complex (Ferrum H) (intramuscular) / a person with –
· iron deficiency anaemia /
18. / Lignocaine hydrochloride 1% plain (injection) / a person with –
· a condition that requires local anaesthesia of the skin /
19. / Metoclopramide (oral) / an adult with –
· nausea
· vomiting /
20. / Metronidazole (oral) / a person with –
· giardia
· trichomonas /
21. / Indomethacin
(rectal suppositories) / an adult with –
· musculoskeletal pain /
22. / Levonorgestrel (oral) / a woman requiring
· post coital emergency contraception (single dose) /
23. / Oseltamivir (oral) / a person with –
· influenza in adults and children aged 1 year and older
· requirement for prevention of influenza in adults and children aged 1 year and older /
24. / Paracetamol / Codeine (oral) / an adult with –
· acute pain /
Approved Medicine / Approved Patient and Condition
25. / Phenoxymethypenicilin
(Penicillin V) (oral) / a person with –
· tonsillitis
· sore throat
· tooth or gum infection
26. / Prednisolone (oral) / a person with –
· moderate to severe asthma (up to 3 doses)
27 / Procaine penicillin (injection) / a person with –
· skin Infection
· pneumonia
· sore throat
· tooth or gum infection
28. / Promethazine hydrochloride (injection) / a person with
· hives
· rash
· allergic reaction
29. / Roxithromycin (oral) / a person with –
· mild / moderate pneumonia
· bronchitis or sinusitis
· sore throat
· skin infection
30. / Salbutamol (solution for inhalation, nebules or metered dose inhaler) / a person with –
· asthma
· bronchitis
31. / Tinidazole (oral) / a person with -
· trichomonas
· giardia
32. / Triamcinolone / Neomycin / Nystatin / Gramicidin (ear drops) / a person with -
· fungal ear infection
33. / Trimethoprim (oral) / a person with –
· urinary tract infection
34. / Valaciclovir or Famciclovir (oral) / a person with –
· genital herpes
· herpes zoster
35. / Zanamivir (oral) / a person with –
· influenza in adults and children aged 5 years and older
· requirement for prevention of influenza in adults and children aged 5 years and older

SASA 003/1-2017Effective from: 30 January 2017 Page 3 of 6